AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
A deep intronic mutation in CDKN2A is associated with disease in a subset of melanoma pedigrees
Authors: Harland, M Mistry, S Bishop, DT Bishop, JAN
Citation: M. Harland et al., A deep intronic mutation in CDKN2A is associated with disease in a subset of melanoma pedigrees, HUM MOL GEN, 10(23), 2001, pp. 2679-2686
A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural systemtumour syndrome family
Authors: Randerson-Moor, JA Harland, M Williams, S Cuthbert-Heavens, D Sheridan, E Aveyard, J Sibley, K Whitaker, L Knowles, M Bishop, JN Bishop, DT
Citation: Ja. Randerson-moor et al., A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural systemtumour syndrome family, HUM MOL GEN, 10(1), 2001, pp. 55-62
Using single nucleotide, polymorphisms to investigate association between a candidate gene and disease
Authors: Saunders, CL Crockford, GP Bishop, DT Barrett, JH
Citation: Cl. Saunders et al., Using single nucleotide, polymorphisms to investigate association between a candidate gene and disease, GENET EPID, 21, 2001, pp. S415-S420
Molecular changes in the Ki-ras and APC genes in colorectal adenomas and carcinomas arising in the same patient
Authors: Zauber, NP Sabbath-Solitare, M Marotta, SP Zauber, AG Bishop, DT
Citation: Np. Zauber et al., Molecular changes in the Ki-ras and APC genes in colorectal adenomas and carcinomas arising in the same patient, J PATHOLOGY, 193(3), 2001, pp. 303-309
Exon deletions and duplications in BRCA1 detected by semiquantitative PCR
Authors: Robinson, MD Chu, CE Turner, G Bishop, DT Taylor, GR
Citation: Md. Robinson et al., Exon deletions and duplications in BRCA1 detected by semiquantitative PCR, GENET TEST, 4(1), 2000, pp. 49-54
The pathology of familial breast cancer: Histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2
Authors: Lakhani, SR Gusterson, BA Jacquemier, J Sloane, JP Anderson, TJ van de Vijver, MJ Venter, D Freeman, A Antoniou, A McGuffog, L Smyth, E Steel, CM Haites, N Scott, RJ Goldgar, D Neuhausen, S Daly, PA Ormiston, W McManus, R Scherneck, S Ponder, BAJ Futreal, PA Peto, J Stoppa-Lyonnet, D Bignon, YJ Struewing, JP Bishop, DT Klijn, JGM Devilee, P Cornelisse, CJ Lasset, C Lenoir, G Barkardottir, RB Egilsson, V Hamann, U Chang-Claude, J Sobol, H Weber, B Easton, DF Stratton, MR
Citation: Sr. Lakhani et al., The pathology of familial breast cancer: Histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2, CLIN CANC R, 6(3), 2000, pp. 782-789
Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours
Authors: Rapley, EA Crockford, GP Teare, D Biggs, P Seal, S Barfoot, R Edwards, S Hamoudi, R Heimdal, K Fossa, SD Tucker, K Donald, J Collins, F Friedlander, M Hogg, D Goss, P Heidenreich, A Ormiston, W Daly, PA Forman, D Oliver, RTD Leahy, M Huddart, R Cooper, CS Bodmer, JG Easton, DF Stratton, MR Bishop, DT
Citation: Ea. Rapley et al., Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours, NAT GENET, 24(2), 2000, pp. 197-200
Mutation screening of the CDKN2A promoter in melanoma families
Authors: Harland, M Holland, EA Ghiorzo, P Mantelli, M Bianchi-Scarra, G Goldstein, AM Tucker, MA Ponder, BAJ Mann, GJ Bishop, DT Bishop, JN
Citation: M. Harland et al., Mutation screening of the CDKN2A promoter in melanoma families, GENE CHROM, 28(1), 2000, pp. 45-57
Lack of linkage between chromosome 5q23-33 markers and IgE/bronchial hyperreactivity in 67 Scottish families
Authors: Mansur, AH Christie, G Turner, A Bishop, DT Markham, AF Helms, P Morrison, JFJ
Citation: Ah. Mansur et al., Lack of linkage between chromosome 5q23-33 markers and IgE/bronchial hyperreactivity in 67 Scottish families, CLIN EXP AL, 30(7), 2000, pp. 954-961
Evidence for a role of HLA DRB1 alleles in the control of IgE levels, strengthened by interacting TCR A/D marker alleles
Authors: Mansur, AH Williams, GA Bishop, DT Markham, AF Lewis, S Britton, J Morrison, JFJ
Citation: Ah. Mansur et al., Evidence for a role of HLA DRB1 alleles in the control of IgE levels, strengthened by interacting TCR A/D marker alleles, CLIN EXP AL, 30(10), 2000, pp. 1371-1378
Isolation of an essential Schizosaccharomyces pombe gene, prp31(+), that links splicing and meiosis
Authors: Bishop, DT McDonald, WH Gould, KL Forsburg, SL
Citation: Dt. Bishop et al., Isolation of an essential Schizosaccharomyces pombe gene, prp31(+), that links splicing and meiosis, NUCL ACID R, 28(11), 2000, pp. 2214-2220
No evidence of germline PTEN mutations in familial prostate cancer
Authors: Forrest, MS Edwards, SM Hamoud, RA Dearnaley, DP Arden-Jones, A Dowe, A Kelly, J Teara, MD Easton, DF Knowles, MA Bishop, DT Eeles, RA
Citation: Ms. Forrest et al., No evidence of germline PTEN mutations in familial prostate cancer, J MED GENET, 37(3), 2000, pp. 210-212
Suggestive evidence for a site specific prostate cancer gene on chromosome1p36
Authors: Badzioch, M Eeles, R Leblanc, G Foulkes, WD Giles, G Edwards, S Goldgar, D Hopper, JL Bishop, DT Moller, P Heimdal, K Easton, D
Citation: M. Badzioch et al., Suggestive evidence for a site specific prostate cancer gene on chromosome1p36, J MED GENET, 37(12), 2000, pp. 947-948
Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations
Authors: Bishop, JAN Wachsmuth, RC Harland, M Bataille, V Pinney, E Mack, P Baglietto, L Cuzick, J Bishop, DT
Citation: Jan. Bishop et al., Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations, J INVES DER, 114(1), 2000, pp. 28-33
Association between loss of heterozygosity of BRCA1 and BRCA2 and morphological attributes of sporadic breast cancer
Authors: Hanby, AM Kelsell, DP Potts, HW Gillett, CE Bishop, DT Spurr, NK Barnes, DM
Citation: Am. Hanby et al., Association between loss of heterozygosity of BRCA1 and BRCA2 and morphological attributes of sporadic breast cancer, INT J CANC, 88(2), 2000, pp. 204-208
Comparison of allelic ratios from paired blood and paraffin-embedded normal tissue for use in a polymerase chain reaction to assess loss of heterozygosity
Authors: Zauber, NP Sabbath-Solitaire, M Marotta, SP McMahon, L Bishop, DT
Citation: Np. Zauber et al., Comparison of allelic ratios from paired blood and paraffin-embedded normal tissue for use in a polymerase chain reaction to assess loss of heterozygosity, MOL DIAGN, 4(1), 1999, pp. 29-35
Suggestive evidence for genetic linkage between IgE phenotypes and chromosome 14q markers
Authors: Mansur, AH Bishop, DT Markham, AF Morton, NE Holgate, ST Morrison, JFJ
Citation: Ah. Mansur et al., Suggestive evidence for genetic linkage between IgE phenotypes and chromosome 14q markers, AM J R CRIT, 159(6), 1999, pp. 1796-1802
N-acetyltransferase (NAT2) genotype and susceptibility to sporadic Alzheimer's disease
Authors: Rocha, L Garcia, C de Mendonca, A Gil, JP Bishop, DT Lechner, MC
Citation: L. Rocha et al., N-acetyltransferase (NAT2) genotype and susceptibility to sporadic Alzheimer's disease, PHARMACOGEN, 9(1), 1999, pp. 9-15
BRCA1 and BRCA2 and breast cancer incidence: A review
Authors: Bishop, DT
Citation: Dt. Bishop, BRCA1 and BRCA2 and breast cancer incidence: A review, ANN ONCOL, 10, 1999, pp. 113-119
Envoplakin, a possible candidate gene for focal NEPPK/esophageal cancer (TOC): The integration of genetic and physical maps of the TOC region on 17q25
Authors: Risk, JM Ruhrberg, C Hennies, HC Mills, HS Di Colandrea, T Evans, KE Ellis, A Watt, FM Bishop, DT Spurr, NK Stevens, HP Leigh, IM Reis, A Kelsell, DP Field, JK
Citation: Jm. Risk et al., Envoplakin, a possible candidate gene for focal NEPPK/esophageal cancer (TOC): The integration of genetic and physical maps of the TOC region on 17q25, GENOMICS, 59(2), 1999, pp. 234-242
Analysis of simulated data: Evidence for genetic and environmental effects
Authors: Crockford, GP Iles, MM Durham, LK Bishop, DT
Citation: Gp. Crockford et al., Analysis of simulated data: Evidence for genetic and environmental effects, GENET EPID, 17, 1999, pp. S527-S532
A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer
Authors: Froggatt, NJ Green, J Brassett, C Evens, DGR Bishop, DT Kolodner, R Maher, ER
Citation: Nj. Froggatt et al., A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer, J MED GENET, 36(2), 1999, pp. 97-102
Site specificity of colorectal neoplasms in families without an inherited syndrome
Authors: Zauber, P Lardieri, G Rathouz, PJ Khan, N Bishop, DT
Citation: P. Zauber et al., Site specificity of colorectal neoplasms in families without an inherited syndrome, GASTROIN EN, 50(5), 1999, pp. 603-607
K-ras mutation and loss of heterozygosity of the adenomatous polyposis coli gene in patients with colorectal adenomas with in situ carcinoma
Authors: Zauber, NP Sabbath-Solitare, M Marotta, SP Bishop, DT
Citation: Np. Zauber et al., K-ras mutation and loss of heterozygosity of the adenomatous polyposis coli gene in patients with colorectal adenomas with in situ carcinoma, CANCER, 86(1), 1999, pp. 31-36
Mutation testing in melanoma families: INK4A, CDK4 and INK4D
Authors: Bishop, JAN Harland, M Bennett, DC Bataille, V Goldstein, AM Tucker, MA Ponder, BAJ Cuzick, J Selby, P Bishop, DT
Citation: Jan. Bishop et al., Mutation testing in melanoma families: INK4A, CDK4 and INK4D, BR J CANC, 80(1-2), 1999, pp. 295-300
Risultati: 1-25 | 26-28